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Doppler echocardiography has largely contributed to show the existence of a distinct diabetic
cardiomyopathy. Several studies have pointed out the evidence of left ventricular (LV)
remodeling and hypertrophy in alterations of both midwall systolic mechanics and LV
diastolic filling in diabetes mellitus (DM), independent of the coexistence of concomitant risk
factors. Further progress will be provided by new ultrasound technologies in this clinical
setting. The combination of pulsed tissue Doppler study of mitral annulus with transmitral
inflow may be clinically valuable for obtaining information about left ventricular filling
pressure (LVFP) and unmasking Doppler inflow pseudonormal pattern, a hinge point for the
progression toward advanced heart failure. In the absence of epicardial coronary artery
stenosis, the ultrasound assessment of coronary flow reserve (CFR) may identify the
dysfunction of coronary microcirculation, in relation with glycemic levels, insulin resistance,
sympathetic overdrive, endothelial dysfunction, abnormalities of the angiotensin-renin
system, and LV remodeling/hypertrophy. Diastolic dysfunction and impairment of CFR may
be associated in DM, with a likely common origin. In this view, a comprehensive
transthoracic Doppler evaluation of diabetic patients should include the assessment of
diastolic function and estimation of LVFP by tissue Doppler, and coronary microvascular
function by CFR test. Additional analysis of regional wall motion during a stress test would
be required in patients with suspected coronary artery disease, another cause of diastolic
dysfunction. (J Am Coll Cardiol 2006;48:1548–51) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.033Cardiology Foundation
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she demonstration of a distinct diabetic cardiomyopathy
as represented a major challenge to echocardiography
Table 1). The journey began in the early 1990s when the
ramingham study showed an increase of left ventricular
LV) mass in diabetic women, independent of the effects of
ther traditional risk factors. In addition, by assessing the
ssociation of age with LV mass, the age coefficient for
iabetic patients was observed to be higher than that for
ondiabetic patients (1). Subsequent studies confirmed
hese results in both genders, highlighting associations of
oth diabetes mellitus (DM) and glucose intolerance with
V structure abnormalities (LV concentric remodeling/
ypertrophy), independent of the influence of relevant
ovariates (2–7). Glucose intolerance and DM were also
ound to negatively affect midwall systolic mechanics (3,4,7)
nd diastolic filling (8), even in the presence of normal
hamber function (4), with an impact amplified by the
oexistence of hypertension (7,8). These findings have now
een complemented by the ability of Doppler techniques to
dentify, categorize, and quantify diastolic dysfunction and
bnormal coronary flow reserve.
iabetes and LV diastolic dysfunction. Doppler pattern
f impaired LV relaxation, characterized by reduced early
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006, accepted June 22, 2006.nd increased late diastolic flow, is an early sign of diastolic
ysfunction (DD) (grade I). More advanced grades, mani-
ested by predominant early diastolic filling and rapid
elocity deceleration (restrictive filling patterns), are associ-
ted with the most severe LV decompensation (9). The
inge point of these grades is the intermediary, pseudonor-
al pattern, which occurs when LV filling pressure (LVFP)
ises to maintain normal cardiac output and increases the
arly filling caused by impaired relaxation. Pseudonormal
nd normal patterns cannot be distinguished by transmitral
nflow because of its preload dependence (9). Accordingly,
he transmitral E/A ratio was found to show a U-shaped
rognostic behavior: subjects with values 0.6 (abnormal
elaxation) and 1.5 (likely restrictive pattern) were both
ssociated with increased mortality, but the intermediate
ange (0.6 to 1.5), encompassing patients with normal or
nidentified pseudonormal patterns, had no significant
rognostic impact (10).
These dynamics are of fundamental importance in study-
ng diabetic patients without coronary artery disease
CAD), who often manifest abnormal LV relaxation while
ystolic function is still normal. When dyspnea becomes
vert, these abnormalities characterize “isolated” diastolic
eart failure. Myocardial fibrosis and apoptosis (11) are
ikely the basis of these changes. Over time, diabetic
atients may transition to a pseudonormal pattern. At this
tage, accurate evaluation of DD requires additional analysis
f Valsalva maneuver, pulmonary venous flow, and/or left
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October 17, 2006:1548–51 Diastole, Coronary Flow Reserve, and Diabetestrial volume determination. In a population of 140 adults
16% diabetic), left atrial volume index was associated with
he degree of DD, independent of ejection fraction, age,
ender, and cardiovascular risk score (12). A pseudonormal
attern was unmasked in 28% of diabetic patients by
alsalva maneuver (E/A ratio decrease 25%) and/or
ulmonary venous flow (atrial reverse velocity duration
onger than mitral A duration) (13). In this context, the
ombination of pulsed tissue Doppler with transmitral
nflow may be extremely useful for characterizing DD and
VFP because early diastolic peak velocity (E=) of the mitral
nnulus reflects the rate of myocardial relaxation and is
elatively insensitive to preload effects (14). The ratio E/E=
E= as average of medial and lateral annulus) has been
alidated as reliable index of LVFP (15). A reduction of
nnular E= was shown in recent-onset type 2 DM (16). In
5 type 1 diabetic patients, an increased E/E= ratio was
ssociated with left atrial enlargement and correlated inde-
endently with glycosylated hemoglobin (17), thus confirm-
ng the association between level of glycemic control and
D (8). The E/E= ratio therefore may be used to detect and
ollow up the progression of DD in DM.
iabetes and coronary microvascular dysfunction. Novel
echniques open intriguing applications for cardiac ultra-
ound in DM. The alterations of myocardial composition
nd, thus, of diastolic properties and LVFP might be
ediated by changes in the coronary microcirculation.
icrovascular damage experienced by the diabetic heart
Abbreviations and Acronyms
CAD  coronary artery disease
CFR  coronary flow reserve
DD  diastolic dysfunction
DM  diabetes mellitus
LV  left ventricular
LVFP  left ventricular filling pressure
able 1. Main Echocardiographic, Population-Based Studies on
Findings
ncrease of LVM in women
ncrease of LVM in both genders
ncrease of LVM, reduction of EFS and MFS
ncrease of LVM and RWT, reduction of MFS
ncrease of LVM and RWT
rogressive increase of LVM and reduction of EFS and MFS
in DM and DM  HTN
rogressive reduction of E/A ratio and prolongation of DT in
DM and DM  HTN
rogressive increase of LVM, RWT, and LA in IGT and DMM  diabetes mellitus; EFS  endocardial fractional shortening; HTN  hypertension;
FS  midwall fractional shortening; RWT  relative wall thickness.18) may lead to myocardial cell injury and reactive fibrosis/
ypertrophy. Although focal microvascular alterations have
ot seemed sufficient to account for diffuse interstitial
brosis (19), these observations looked at structure but not
ynamics of coronary microvessels. Today, the function of
oronary circulation may be evaluated by transthoracic
chocardiography, by visualizing the distal left anterior
escending artery (20–22), and by measuring coronary flow
eserve (CFR) as hyperemic to the resting velocities ratio
20–22). The CFR has excellent concordance with intra-
oronary Doppler flow wire-derived CFR (20), high feasi-
ility (21), and reproducibility (21). In the absence of
picardial coronary stenosis, impaired CFR indicates coro-
ary microvascular dysfunction (22). A reduction of CFR
as been documented in both type 1 and type 2 DM and
eems to be a direct consequence of elevated glycemia
23,24). An alternative explanation is insulin resistance,
hich alters CFR during a cold pressure test, a completely
ndothelium-dependent stimulus (25). Endothelial func-
ion, another possible determinant of CFR, is impaired in
arly DM (26). Also, increased cardiac sympathetic activity
ay account for abnormal CFR in diabetic patients (27).
he link between coronary microvascular and diastolic
ysfunction in diabetes. Diastolic dysfunction is evident in
ype 1 diabetic patients free of CAD when CFR impair-
ent is also detectable (27). A similar relationship between
he magnitude of CFR reduction and the degree of myo-
ardial DD was found in uncomplicated hypertension (28),
nother condition characterized by impaired coronary mi-
rocirculation. This association is not surprising because
oronary flow occurs predominantly during diastole. A
hange in the time constant of LV isovolumic pressure fall
), measured by catheterization, is associated with de-
reased coronary flow even in patients without CAD (29).
oth reduced CFR and DD are associated with insulin
esistance (26,30), with LV concentric remodeling/
ypertrophy (8,31), with disorders of the sympathetic ner-
etic Cardiomyopathy
lation Sample (n) Authors Year
1 DM
1 IGT
Galderisi et al. (1)
Framingham Heart Study
1991
97 DM or IGT
5 yrs
Lee et al. (2)
Cardiovascular Health Study
1997
10 DM Devereux et al. (3)
Strong Heart Study
2000
6 DM HTN Palmeri et al. (4)
HyperGEN Study
2001
7 IGT Ilercil et al. (5)
Strong Heart Study
2001
2 DM
4 DM HTN
Bella et al. (7)
Strong Heart Study
2001
6 DM
1 DM HTN
Liu et al. (8)
Strong Heart Study
2001
6 DM
3 IGT
Rutter et al. (6)
Framingham Heart Study
2003Diab
Popu
11
38
2,6
6
1,8
38
45
64
87
61
67
18
34IGT  impaired glucose tolerance; LA  left atrium; LVM  left ventricular mass;
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Diastole, Coronary Flow Reserve, and Diabetes October 17, 2006:1548–51ous system (27), with abnormalities of the angiotensin-
enin system (32), and with endothelial dysfunction (33).
e can, therefore, suppose that coronary microvascular
amage plays a mechanistic role for DD (34) or even vice
ersa, considering DD as the main expression of myocardial
brosis. Determinants of microvascular dysfunction in DM,
uch as hyperglycemia and insulin resistance, and factors
ncluding sympathetic overdrive, endothelial dysfunction,
nd LV concentric remodeling, also contribute to the
evelopment of DD. Systolic failure may be a further
onsequence because of impairment of both diastolic prop-
rties and coronary microcirculation (Fig. 1). In my view, a
omprehensive transthoracic Doppler evaluation of diabetic
atients should include assessment of diastolic function with
stimation of LVFP by tissue Doppler, and of coronary
icrovascular function by CFR test. Analysis of regional
all motion during stress would be required in patients with
uspected CAD, another cause of DD. The detection of
all motion abnormalities cannot be ascribed to microvas-
ular dysfunction but has to be considered a true expression
f epicardial artery stenosis (macrovascular disease).
linical implications. The journey of Doppler echocardi-
graphy in the assessment of diabetic heart disease is not yet
omplete. Ultrasound identifies early diastolic involvement
nd progression toward more severe DD by detecting
hanges of LVFP. Future potential links between diastolic
ehavior and the state of coronary microcirculation will be
xamined by combined imaging of coronary flow dynamics
nd global/regional diastolic function. This will be useful for
reclinical diagnosis, risk stratification, and therapeutic
anagement of the cardiac involvement in diabetes melli-
igure 1. The hypothetical link of metabolic alterations to left ventricular (L
nsulin resistance, sympathetic overdrive, endothelial dysfunction, abnorma
ay induce diastolic dysfunction (DD) and impairment of the coronary mi
V systolic involvement appears subsequent to DD and/or coronary micro
lling pressure (Doppler mitral inflow  mitral annular tissue Doppler)
unction. CFR  coronary flow reserve; MFS  midwall fractional shortus. These findings may enable the value of cardiac drugs,uch as angiotensin-converting enzyme inhibitors, selective
lockers of angiotensin II type receptors, aldosterone antag-
nists, beta-blockers, and even statins, to be documented so
hat these agents may be applied more appropriately. The
esponse to tight glycemic control by diet and new insulin-
ensitizing agents could be followed up to determine
hether a parallel reversal of myocardial and microvessel
odifications could be achieved.
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